| Literature DB >> 34235042 |
Percy Rossell-Perry1,2, Arquimedes Gavino-Gutierrez1,3.
Abstract
BACKGROUND: The COVID-19 pandemic has caused a negative impact in every sector of life, especially in the health sector. Patients with different medical conditions are suffering delays in their surgical treatments. Cleft lip and palate is a common congenital disease that requires early interdisciplinary attention, and there is uncertainty about the safety of performing its surgical treatment during the COVID-19 pandemic. The objective of this study was to evaluate the safety of a surgical cleft protocol for cleft lip and palate used during the COVID-19 pandemic at a high volume cleft center in Lima, Peru.Entities:
Year: 2021 PMID: 34235042 PMCID: PMC8245116 DOI: 10.1097/GOX.0000000000003692
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Protocol for Primary Cleft Lip and Palate Repair
| Cleft Type | Surgical Technique |
|---|---|
| Cleft lip nose | |
| Unilateral cleft lip | Modification of Pool’s technique + VYZ rhinoplasty (rotational composite flap rhinoplasty for the pandemic group) |
| Bilateral cleft lip | Straight lines closure + VYZ rhinoplasty (rotational composite flap rhinoplasty for the pandemic group) Bilateral lip adhesion for severe forms |
| Cleft palate | |
| Incomplete cleft palate | Furlow or Von Langenbeck techniques |
| Unilateral cleft palate | One flap technique |
| Bilateral cleft palate | Von Langenbeck technique or delayed hard palate closure (severe forms) |
*According to the Lima Protocol for primary cleft palate repair.[9]
Characteristics of the Studied Groups
| Pre-pandemic (N = 92) | Pandemic (N = 80) | ||
|---|---|---|---|
| Gender | |||
| Boys | 52 (56.52%) | 44 (55%) | 0.841 |
| Girls | 40 (43.48%) | 36 (45%) | |
| Type of cleft | |||
| Unilateral cleft lip | 25 (27.17%) | 22 (27.5%) | |
| Bilateral cleft lip | 16 (17.39%) | 15 (18.75%) | |
| Incomplete cleft palate | 11 (11.95%) | 8 (10%) | 0.995 |
| Unilateral cleft palate | 26 (28.26%) | 23 (28.75%) | |
| Bilateral cleft palate | 14 (15.21%) | 12 (15%) |
*Chi-squared test; CI level: 95%.
Fig. 2.Comparison of age at the time of surgery, between pandemic and pre-pandemic groups.
Fig. 3.Comparison of operative time, between pandemic and pre-pandemic groups.
Age at the Time of Surgery Comparison between Pandemic (N = 80) and Pre-pandemic Groups (N = 92)
| Type of Surgery | Age (mo)* | ||
|---|---|---|---|
| Pre-pandemic | Pandemic | ||
| Lip adhesion | 3.25 (0.5) | 9.25 (3.5) | 0.01 |
| Unilateral lip repair | 4.12 (0.97) | 6.27 (2.19) | 0.0001 |
| Bilateral lip repair | 4.33 (0.89) | 7 (2.86) | 0.006 |
| Incomplete cleft palate repair | 12 (1.41) | 14.25 (2.43) | 0.01 |
| Unilateral cleft palate repair | 12.3 (1.43) | 17.65 (5.47) | 0.00001 |
| Bilateral cleft palate repair | 12.57 (1.28) | 20.08 (7.14) | 0.0007 |
*Values given are in mean (SD).
†Student’s T-test; CI level 95%.
Comparison of Operative Time between Pandemic (N = 80) and Pre-pandemic Groups (N = 92)
| Type of Surgery | Operative Time (min)* | ||
|---|---|---|---|
| Pre-pandemic | Pandemic | ||
| Lip adhesion | 46 (9.69) | 44.5 (10.47) | 0.84 |
| Unilateral cleft lip repair | 74.04 (11.09) | 62.68 (8.43) | 0.0003 |
| Bilateral cleft lip repair | 81.42 (7.32) | 70.36 (13.77) | 0.002 |
| Incomplete cleft palate repair | 57.36 (11.26) | 49.5 (9.17) | 0.12 |
| Unilateral cleft palate repair | 70.73 (10.65) | 58.57 (11.02) | 0.0003 |
| Bilateral cleft palate repair | 74.64 (10.12) | 61.67 (11.04) | 0.005 |
*Values given are in mean (SD).
†Student’s T-test; CI level 95%.
Comparison of Preoperative Screening between Pandemic (N = 80) and Pre-pandemic Groups (N = 92)
| Measurements (units) | Pre-pandemic* | Pandemic* | |
|---|---|---|---|
| Hemoglobin (g/dL) | 11.37 (0.85) | 11.89 (0.93) | 0.0002 |
| Leukocytes (109/L) | 9.56 (2.28) | 9.17 (2.3) | 0.27 |
| Platelets (109/L) | 343.76 (63.88) | 340.19 (64.67) | 0.87 |
| Clotting time (min) | 6.97 (0.75) | 6.85 (0.88) | 0.89 |
| Bleeding time (min) | 2.01 (0.31) | 1.98 (0.45) | 0.54 |
| Glucose (mg/dL) | 86.80 (6.67) | 88.26 (7.56) | 0.67 |
| Urea (mg/dL) | 22.40 (4.29) | 22.31 (5.30) | 0.90 |
| Creatinine (mg/dL) | 0.54 (2.79) | 0.26 (0.05) | 0.36 |
*Values given are in mean (SD).
† Student’s T-test; CI level 95%.
Comparison of Postoperative Vital Signs between Pandemic (N = 80) and Pre-pandemic Group (N = 92)
| Measurements | Pre-pandemic* | Pandemic* | |
|---|---|---|---|
| Oxygen saturation PACU | 98.17 (0.76) | 98.03 (0.81) | 0.22 |
| Temperature PACU | 36.56 (0.35) | 36.35 (0.34) | 0.96 |
| Pulse rate PACU | 118.9 (7.56) | 118 (10.36) | 0.51 |
| Respiration rate PACU | 24.57 (2.62) | 24.78 (2.99) | 0.64 |
| Temperature | 37.26 (0.60) | 37.09 (0.59) | 0.05 |
| Pulse rate | 124.46 (6.32) | 123.03 (8.89) | 0.22 |
| Respiration rate | 25.62 (2.24) | 25.68 (2.26) | 0.87 |
*Values given are in mean (SD).
† Last measurements in PACU.
‡ Vital signs during first 24 horas after PACU and registered by nurses.
§ Student’s T-test; CI Confident level 95%.
Comparison of Nonsurgical Complications between Pandemic (N = 80) and Pre-pandemic Groups (N = 92)
| Measurements | Pre-pandemic | Pandemic | |
|---|---|---|---|
| Lip nose surgery | N = 41 | N = 37 | |
| Fever during first 72 h | 10 (27.02%) | 11 (29.72%) | 0.51 |
| Fever after 72 h | 5 (12.19%) | 1 (2.70%) | 0.44 |
| Diarrhea | 7 (17.07%) | 4 (10.81%) | 0.36 |
| Cough | 9 (21.95%) | 6 (16.21%) | 0.64 |
| Palate surgery | N = 51 | N = 43 | |
| Fever during first 72 h | 33 (64.70%) | 25 (58.13%) | 0.37 |
| Fever after 72 h | 7 (13.72%) | 6 (13.95%) | 0.61 |
| Diarrhea | 10 (19.60%) | 6 (13.95%) | 0.62 |
| Otitis | 4 (7.84%) | 2 (4.65%) | 0.55 |
| Cough | 17 (33.33%) | 12 (27.90%) | 0.35 |
* Fisher’s exact test; CI level 95%.
Comparison of Surgical Complications between Pandemic (N = 80) and Pre-pandemic Group (N = 92)
| Measurements | Pre-pandemic | Pandemic | |
|---|---|---|---|
| Lip | N = 41 | N = 37 | |
| Infection | 1 (2.43%) | 2 (5.40%) | 0.74 |
| Granuloma | 5 (12.19%) | 3 (8.10%) | 0.53 |
| Dehiscence (partial) | 2 (4.87%) | 2 (5.40%) | 0.56 |
| Palate | N = 51 | N = 43 | |
| Infection | 1 (1.96%) | 0 | |
| Dehiscence (partial) | 2 (3.92%) | 1 (2.32%) | 0.72 |
| Fistula | 2 (3.92%) | 2 (4.65%) | 0.56 |
* Fisher’s exact test; CI level 95%.